CI vs HRMY · P/E 2.4, rev $274.90B vs P/E 14, rev $714.7M
Cigna Corp (CI) versus Harmony Biosciences Holdings (HRMY) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Harmony Biosciences Holdings (HRMY) is a biotechnology company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported HRMY revenue for 2024-12-31 was $714.7M. Net income was $145.5M. Revenue was up 22.8% from 2023-12-31 to 2024-12-31. HRMY currently screens at market cap $1.96B and trailing P/E 13.6.
CI currently screens at market cap $71.62B and trailing P/E 2.4. HRMY currently screens at market cap $1.96B and trailing P/E 13.6.
Not investment advice. Open the CI and HRMY stock pages for the full models.
Not investment advice.